Cellectis SA (STU:ZVAA)
€ 1.48 -0.03 (-1.99%) Market Cap: 148.13 Mil Enterprise Value: -4.47 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 49/100

Q4 2022 Cellectis SA Earnings Call Transcript

Mar 09, 2023 / 01:00PM GMT
Release Date Price: €1.88
Operator

Good morning, everyone, and welcome to Cellectis Fourth Quarter and Full Year 2022 Earnings Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded. I would now like to introduce you the first speaker Arthur Stril, Chief Business Officer. You may begin.

Arthur Stril
Cellectis S.A. - Chief Business Officer

Good morning, and welcome, everyone, to Cellectis Fourth Quarter and Full Year 2022 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks are Dr. Andre Choulika, our Chief Executive Officer; Dr. Bing Wang, our Chief Financial Officer; and Dr. Mark Frattini, our Chief Medical Officer.

Yesterday evening, Cellectis issued a press release reporting its financial results for the Fourth Quarter and Full Year 2022 ended December 31, 2022. The press release is available on our website at cellectis.com. We expect to file the annual reports in the coming days.

As a reminder, we will make statements regarding Cellectis' financial outlook in addition to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot